IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases

References

• Masaki Y, Shimizu H, Sato Nakamura T, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematop. 2014;54(2):95–101. doi: 10.3960/jslrt.54.95
   PubMedGoogle Scholar
• Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet. 2015;385(9976):1460–1471. doi: 10.1016/S0140-6736(14)60720-0
   PubMed Web of Science ®Google Scholar
• Bledsoe JR, Della-Torre E, Rovati L, et al. IgG4-related disease: review of the histopathologic features, differential diagnosis, and therapeutic approach. APMIS. 2018;126(6):459–476. doi: 10.1111/apm.12845
   PubMed Web of Science ®Google Scholar
• Chen LYC, Mattman A, Seidman MA, et al. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104(3):444–455. doi: 10.3324/haematol.2018.205526
   PubMed Web of Science ®Google Scholar
• Qi R, Chen LYC, Park S, et al. Utility of serum IgG4 levels in a multiethnic population. Am J Med Sci. 2018;355(1):61–66. doi: 10.1016/j.amjms.2017.08.014
   PubMed Web of Science ®Google Scholar
• Varghese JL, Fung AWS, Mattman A, et al. Clinical utility of serum IgG4 measurement. Clin Chim Acta. 2020;506:228–235. doi: 10.1016/j.cca.2020.04.001
   PubMed Web of Science ®Google Scholar
• Zhao EJ, Carruthers MN, Li CH, et al. Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center. Haematologica. 2020;105(3):e121–e123. doi: 10.3324/haematol.2019.219725
   PubMed Web of Science ®Google Scholar
• Moller D, Tan J, Gauiran DTV, et al. Causes of hypereosinophilia in 100 consecutive patients. Eur J Haematol. 2020;105(3):292–301. doi: 10.1111/ejh.13437
   PubMed Web of Science ®Google Scholar
• Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–1192. doi: 10.1038/modpathol.2012.72
   PubMed Web of Science ®Google Scholar
• Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020;79(1):77–87. doi: 10.1136/annrheumdis-2019-216561
   PubMed Web of Science ®Google Scholar
• Kunkel HG, Fahey JL, Franklin EC, et al. Notation for human immunogobulin subclasses. Bull World Health Organ. 1966;35(6):953.
   PubMed Web of Science ®Google Scholar
• Terry WD, Fahey JL. Subclasses of human gamma-2-globulin based on differences in the heavy polypeptide chains. Science. 1964;146(3642):400–401. doi: 10.1126/science.146.3642.400
   PubMedGoogle Scholar
• Grey HM, Kunkel HG. H chain subgroups of myeloma proteins and normal 7s gamma-globulin. J Exp Med. 1964;120:253–266. doi: 10.1084/jem.120.2.253
   PubMed Web of Science ®Google Scholar
• Geyer JT, Niesvizky R, Jayabalan DS, et al. IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease. Mod Pathol. 2014;27(3):375–381. doi: 10.1038/modpathol.2013.159
   PubMed Web of Science ®Google Scholar
• Kato S, Kuwatani M, Kawakubo K, et al. Hepatobiliary and pancreatic: pancreatic cancer with elevated serum IgG4 level due to multiple myeloma mimicking localized autoimmune pancreatitis. J Gastroenterol Hepatol. 2018;33(7):1310. doi: 10.1111/jgh.14088
   PubMed Web of Science ®Google Scholar
• Zhu J, Wu B. Immunoglobulin G4-positive plasma cell myeloma. Blood. 2015;126(19):2254. doi: 10.1182/blood-2015-08-663492
   PubMed Web of Science ®Google Scholar
• van der Gugten G, DeMarco ML, Chen LYC, et al. Resolution of spurious immunonephelometric IgG subclass measurement discrepancies by LC-MS/MS. Clin Chem. 2018;64(4):735–742. doi: 10.1373/clinchem.2017.282319
   PubMed Web of Science ®Google Scholar
• Greipp PR, Raymond NM, Kyle RA, et al. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood. 1985;65(2):305–310. doi: 10.1182/blood.V65.2.305.305
   PubMed Web of Science ®Google Scholar
• Goasguen JE, Zandecki M, Mathiot C, et al. Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leuk Res. 1999;23(12):1133–1140. doi: 10.1016/S0145-2126(99)00132-0
   PubMed Web of Science ®Google Scholar
• Papadea C, Reimer CB, Check IJ. Igg subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance. Ann Clin Lab Sci. 1989;19(1):27–37. doi: 10.3109/10408368909106589
   PubMed Web of Science ®Google Scholar
• Aucouturier P, Preud'Homme JL. Subclass distribution of human myeloma proteins as determined with monoclonal antibodies. Immunol Lett. 1987;16(1):55–57. doi: 10.1016/0165-2478(87)90061-7
   PubMed Web of Science ®Google Scholar
• Hubers LM, Vos H, Schuurman AR, et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2018;67(4):728–735.
   PubMed Web of Science ®Google Scholar
• Perugino CA, AlSalem SB, Mattoo H, et al. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol. 2019;143(2):736–745.e6. doi: 10.1016/j.jaci.2018.05.011
   PubMed Web of Science ®Google Scholar
• Liu H, Perugino CA, Ghebremichael M, et al. Disease severity linked to increase in autoantibody diversity in IgG4-related disease. Arthritis Rheumatol. 2020;72(4):687–693. doi: 10.1002/art.41140
   PubMed Web of Science ®Google Scholar
• Della-Torre E, Rigamonti E, Perugino C, et al. B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. J Allergy Clin Immunol. 2020;145(3):968–981.e914. doi: 10.1016/j.jaci.2019.07.004
   PubMed Web of Science ®Google Scholar
• Mattman A, Chen LYC, van der Gugten G, et al. In IgG4 related disease, elevated IgG2 is an artifact not a biomarker. Semin Arthritis Rheum. 2020;50(2):e8. doi: 10.1016/j.semarthrit.2019.08.002
   PubMedGoogle Scholar
• Ito A, Yamauchi T, Nakano A, et al. Igg4 plasma cell myeloma: clinicopathological characteristics and diagnosis. Pathol Int. 2020;70(8):551–556. doi: 10.1111/pin.12968
   PubMed Web of Science ®Google Scholar